IGM Biosciences Inc (IGMS)
9.29
-0.20
(-2.11%)
USD |
NASDAQ |
May 16, 16:00
9.29
0.00 (0.00%)
After-Hours: 20:00
IGM Biosciences Total Liabilities (Quarterly): 214.88M for March 31, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 214.88M |
December 31, 2023 | 220.18M |
September 30, 2023 | 220.49M |
June 30, 2023 | 222.05M |
March 31, 2023 | 223.31M |
December 31, 2022 | 226.24M |
September 30, 2022 | 212.76M |
June 30, 2022 | 206.79M |
March 31, 2022 | 53.22M |
December 31, 2021 | 53.22M |
September 30, 2021 | 46.65M |
Date | Value |
---|---|
June 30, 2021 | 28.21M |
March 31, 2021 | 24.86M |
December 31, 2020 | 26.82M |
September 30, 2020 | 23.54M |
June 30, 2020 | 22.10M |
March 31, 2020 | 19.14M |
December 31, 2019 | 21.12M |
September 30, 2019 | 15.23M |
June 30, 2019 | 6.701M |
December 31, 2018 | 69.81M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
6.701M
Minimum
Jun 2019
226.24M
Maximum
Dec 2022
104.38M
Average
49.94M
Median
Total Liabilities (Quarterly) Benchmarks
Akoya Biosciences Inc | 122.03M |
Xilio Therapeutics Inc | 56.84M |
NovaBay Pharmaceuticals Inc | 5.197M |
Palatin Technologies Inc | 24.94M |
iBio Inc | 24.82M |
Total Liabilities (Quarterly) Related Metrics
Total Assets (Quarterly) | 376.13M |
Shareholders Equity (Quarterly) | 161.25M |
Current Ratio | 7.982 |